NYT vs PSO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NYT · New York Times$68.36 ▲ 4.26%
PSO · Pearson$17.27 ▼ 1.37%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NYT +10.1%
- PSO +35.2%
Head to head
| Metric | NYT | PSO |
|---|---|---|
| Price | $68.36 | $17.27 |
| Change today | ▲ 4.26% | ▼ 1.37% |
| Market cap | $10.93B | $10.38B |
| Return, 3 months | +5.5% | +5.8% |
| Return, year to date | -0.7% | +26.1% |
| Return, 1 year | +12.4% | +35.6% |
| P/E (TTM) | 27.3 | 25.7 |
| P/B | 5.3 | 2.3 |
| P/E percentile vs own 5y | 19th | 83rd |
| Dividend yield | 1.54% | 1.98% |
| Revenue growth (YoY, latest qtr) | +11.2% | +10.3% |
| Net profit growth (YoY) | +12.6% | -2.2% |
| Gross margin | 51.4% | 52.0% |
| Operating margin | 16.6% | 16.9% |
| Net margin | 13.2% | 8.8% |
| Return on equity | 19.7% | 9.2% |
| Analyst target vs. price | +15.6% | +7.1% |
| Analyst buy share | 71% | 0% |
| RSI (14) | 52 | 49 |
| 30-day volatility | 27.7% | 23.5% |
| Max drawdown, 1 year | -27.7% | -18.3% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NYT is the largest of the group by market value.
- PSO has returned the most over the past year.
- PSO carries the lowest trailing P/E.
- PSO pays the highest dividend yield.
- NYT is growing revenue fastest.
- NYT keeps the most profit per dollar of sales.
- PSO has been the calmest stock over the last 30 days.